Literature DB >> 10331089

Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

S V Ambudkar1, S Dey, C A Hrycyna, M Ramachandra, I Pastan, M M Gottesman.   

Abstract

Considerable evidence has accumulated indicating that the multidrug transporter or P-glycoprotein plays a role in the development of simultaneous resistance to multiple cytotoxic drugs in cancer cells. In recent years, various approaches such as mutational analyses and biochemical and pharmacological characterization have yielded significant information about the relationship of structure and function of P-glycoprotein. However, there is still considerable controversy about the mechanism of action of this efflux pump and its function in normal cells. This review summarizes current research on the structure-function analysis of P-glycoprotein, its mechanism of action, and facts and speculations about its normal physiological role.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331089     DOI: 10.1146/annurev.pharmtox.39.1.361

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  475 in total

1.  ABC1: connecting yellow tonsils, neuropathy, and very low HDL.

Authors:  H H Hobbs; D J Rader
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Drug Interactions with Antiretrovirals.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

3.  The E23 early gene of Drosophila encodes an ecdysone-inducible ATP-binding cassette transporter capable of repressing ecdysone-mediated gene activation.

Authors:  T Hock; T Cottrill; J Keegan; D Garza
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 4.  Additional transporter characterization may lead to new pharmaceutical opportunities.

Authors:  O S Gudmundsson
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

5.  Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins.

Authors:  Guido J E J Hooiveld; Janette Heegsma; Jessica E van Montfoort; Peter L M Jansen; Dirk K F Meijer; Michael Müller
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Structural basis for cooperative DNA binding by two dimers of the multidrug-binding protein QacR.

Authors:  Maria A Schumacher; Marshall C Miller; Steve Grkovic; Melissa H Brown; Ronald A Skurray; Richard G Brennan
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

7.  Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.

Authors:  Maya K Leabman; Conrad C Huang; Joseph DeYoung; Elaine J Carlson; Travis R Taylor; Melanie de la Cruz; Susan J Johns; Doug Stryke; Michiko Kawamoto; Thomas J Urban; Deanna L Kroetz; Thomas E Ferrin; Andrew G Clark; Neil Risch; Ira Herskowitz; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

8.  Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin.

Authors:  Masanori Horinouchi; Toshiyuki Sakaeda; Tsutomu Nakamura; Yoshinori Morita; Takao Tamura; Nobuo Aoyama; Masato Kasuga; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

9.  Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.

Authors:  Shahrooz Vahedi; Eduardo E Chufan; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2017-07-17       Impact factor: 5.858

10.  The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines.

Authors:  Sung-Han Hsiao; Megumi Murakami; Ni Yeh; Yan-Qing Li; Tai-Ho Hung; Yu-Shan Wu; Suresh V Ambudkar; Chung-Pu Wu
Journal:  Cancer Lett       Date:  2018-07-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.